➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Harvard Business School
Express Scripts
Dow
Johnson and Johnson

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Ornidazole


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Ornidazole?

Ornidazole is an investigational drug.

There have been 7 clinical trials for Ornidazole. The most recent clinical trial was a Phase 2 trial, which was initiated on March 3rd 2018.

The most common disease conditions in clinical trials are Recurrence, Crohn Disease, and Colonic Neoplasms. The leading clinical trial sponsors are Assistance Publique - Hôpitaux de Paris, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and Alfasigma S.p.A.

There are five hundred and twenty-four US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Ornidazole
TitleSponsorPhase
Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer SurgeryAssistance Publique - Hôpitaux de ParisPhase 3
Mechanical Bowel Preparation and Oral Antibiotics Before Rectal Cancer SurgeryAssistance Publique - Hôpitaux de ParisPhase 3
Metronidazole as an Adjunct of Non- Surgical Treatment of Peri-implantitisOsteology FoundationPhase 4

See all Ornidazole clinical trials

Clinical Trial Summary for Ornidazole

Top disease conditions for Ornidazole
Top clinical trial sponsors for Ornidazole

See all Ornidazole clinical trials

US Patents for Ornidazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ornidazole   Get Started Free Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA)   Get Started Free
Ornidazole   Get Started Free Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   Get Started Free
Ornidazole   Get Started Free Drug device configured for wireless communication Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ)   Get Started Free
Ornidazole   Get Started Free Treatments for gastrointestinal conditions Board of Regents, The University of Texas System (Austin, TX) St. Jude Children's Research Hospital, Inc. (Memphis, TN)   Get Started Free
Ornidazole   Get Started Free Boron-containing small molecules as antiprotozoal1 agents MMV MEDICINES FOR MALARIA VENTURE (Geneva, CH)   Get Started Free
Ornidazole   Get Started Free Cadotril particles Johnson & Johnson Consumer Inc. (Skillman, NJ)   Get Started Free
Ornidazole   Get Started Free Engineered nucleic acids and methods of use thereof ModernaTX, Inc. (Cambridge, MA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ornidazole

Drugname Country Document Number Estimated Expiration Related US Patent
Ornidazole European Patent Office EP2981556 2033-04-02   Get Started Free
Ornidazole World Intellectual Property Organization (WIPO) WO2014165513 2033-04-02   Get Started Free
Ornidazole World Intellectual Property Organization (WIPO) WO2014052836 2032-09-27   Get Started Free
Ornidazole European Patent Office EP3151906 2034-06-03   Get Started Free
Ornidazole European Patent Office EP3643355 2034-06-03   Get Started Free
Ornidazole World Intellectual Property Organization (WIPO) WO2015187289 2034-06-03   Get Started Free
Ornidazole European Patent Office EP3116499 2034-03-12   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Johnson and Johnson
Dow
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.